Refractory treatment in resource-limited settings.
作者信息
Mahadeva Sanjiv
机构信息
Division of Gastroenterology, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia.
出版信息
JGH Open. 2023 Jun 24;7(6):401-402. doi: 10.1002/jgh3.12934. eCollection 2023 Jun.
Abstract
摘要
相似文献
1
Refractory treatment in resource-limited settings.资源有限环境下的难治性治疗。
JGH Open. 2023 Jun 24;7(6):401-402. doi: 10.1002/jgh3.12934. eCollection 2023 Jun.
2
Treatment of refractory infection: A new challenge for clinicians.难治性感染的治疗：临床医生面临的新挑战。
Front Microbiol. 2022 Oct 18;13:998240. doi: 10.3389/fmicb.2022.998240. eCollection 2022.
3
Effect of helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection.幽门螺杆菌根除对感染幽门螺杆菌的青春期女孩缺铁性难治性贫血的影响。
Acta Paediatr. 2000 Feb;89(2):154-7. doi: 10.1080/080352500750028753.
4
Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.新型免疫球蛋白 Y 在难治性幽门螺杆菌感染患者中的真实世界疗效和安全性证据。
BMC Infect Dis. 2024 Jun 27;24(1):647. doi: 10.1186/s12879-024-09498-4.
5
Investigation of a Possible Association Between Refractory Iron Deficiency Anaemia to an Underlying Remote Helicobacter pylori Infection.难治性缺铁性贫血与潜在的隐匿性幽门螺杆菌感染之间可能存在关联的调查。
J Egypt Public Health Assoc. 2009;84(1-2):141-68.
6
A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.一项对幽门螺杆菌根除治疗耐药的胃黏膜相关淋巴组织淋巴瘤放疗 5 年疗效的回顾性研究。
Jpn J Clin Oncol. 2013 Sep;43(9):917-22. doi: 10.1093/jjco/hyt097. Epub 2013 Jul 21.
7
Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.14 天改良伴随疗法治疗难治性幽门螺杆菌感染的疗效和安全性：一项初步研究。
J Gastroenterol Hepatol. 2023 Dec;38(12):2097-2103. doi: 10.1111/jgh.16348. Epub 2023 Sep 13.
8
9
Third-line and rescue therapy for refractory infection: A systematic review.三线及挽救治疗难治性感染：系统评价。
World J Gastroenterol. 2023 Jan 14;29(2):390-409. doi: 10.3748/wjg.v29.i2.390.
10
Refractory infection and the gastric microbiota.难治性感染与胃微生物群。
Front Cell Infect Microbiol. 2022 Sep 27;12:976710. doi: 10.3389/fcimb.2022.976710. eCollection 2022.
引用本文的文献
1
Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant .含500毫克三水合阿莫西林和125毫克左氧氟沙星用于根除耐药菌的胃滞留漂浮组合片的研制
Pharmaceutics. 2024 Sep 24;16(10):1242. doi: 10.3390/pharmaceutics16101242.
本文引用的文献
1
The prevalence and treatment outcomes of infection in a tertiary hospital in Thailand, 2018-2021.2018 - 2021年泰国一家三级医院感染的患病率及治疗结果
JGH Open. 2023 May 26;7(6):439-444. doi: 10.1002/jgh3.12916. eCollection 2023 Jun.
2
A Malaysian consensus report on the diagnosis and treatment of infection.一份关于感染诊断与治疗的马来西亚共识报告。
JGH Open. 2023 Mar 27;7(4):261-271. doi: 10.1002/jgh3.12886. eCollection 2023 Apr.
3
Searching for an optimal therapy for H pylori eradication: High-dose proton-pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days.寻找 H pylori 根除的最佳治疗方法：高剂量质子泵抑制剂双联疗法加阿莫西林与标准三联疗法 14 天疗法比较。
Helicobacter. 2020 Oct;25(5):e12723. doi: 10.1111/hel.12723. Epub 2020 Jul 26.
4
eradication therapy to prevent gastric cancer: systematic review and meta-analysis.根除疗法预防胃癌：系统评价和荟萃分析。
Gut. 2020 Dec;69(12):2113-2121. doi: 10.1136/gutjnl-2020-320839. Epub 2020 Mar 23.
5
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.基因耐药指导与经验性治疗对难治性幽门螺杆菌感染的疗效比较。
Gastroenterology. 2018 Oct;155(4):1109-1119. doi: 10.1053/j.gastro.2018.06.047. Epub 2018 Jun 30.
6
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
7
Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?1 周质子泵抑制剂三联疗法作为一线幽门螺杆菌根除方案在亚洲患者中的疗效：10 年后是否仍然有效？
J Dig Dis. 2010 Aug;11(4):244-8. doi: 10.1111/j.1751-2980.2010.00445.x.
8
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.《第二届亚太地区幽门螺杆菌感染共识指南》
J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600. doi: 10.1111/j.1440-1746.2009.05982.x.
9
Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.与及时进行内镜检查相比，幽门螺杆菌“检测与治疗”策略在亚洲年轻消化不良患者中的成本效益及满意度
Gut. 2008 Sep;57(9):1214-20. doi: 10.1136/gut.2007.147728. Epub 2008 Apr 25.
10
Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.幽门螺杆菌阳性消化性溃疡疾病的根除治疗：系统评价与经济分析
Am J Gastroenterol. 2004 Sep;99(9):1833-55. doi: 10.1111/j.1572-0241.2004.40014.x.
Zotero 插件